ReviewJournal of human hypertension2022

Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection.

Biplab K MaitiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.